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A series of 3-(2-substituted sulfanyl-imidazo [2,1-b][1,3,4] thiadiazol-6-yl)-chromen-2-ones (3) have been synthesized 
from 3-(2-bromo acetyl) chromen-2-ones 1 and 2-amino-5-thio substituted[1,3,4]thiadiazole 2 in anhydrous ethanol.  
The 7,8-benzo analogs of 3-(2-substituted sulfanyl-imidazo[2,1-b][1,3,4] thiadiazol-6-yl)-chromen-2-ones 5 have been 
synthesized under similar conditions. All the synthesized compounds have been characteriszed by analytical and  
spectral data.  
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The imidazo[2,1-b][1,3,4]thiadiazole system is present 
on Levamisole, a well known immuno modulator
6
. The 
thiazole (sulfathiazole / cerfixime)
7
, imidazo[2,1-






 are regarded as safer and better drug 




In continuation of our earlier work on the synthesis 
of heterocyclic systems derived from coumarin
11-13
 
and also our search for biologically active imidazo 
[2,1-b][1,3,4] thiadiazoles
14
, we report here in the 
synthesis and preliminary biological evaluation of 
some 3-(2-substituted sulfanyl-imidazo [2,1-b][1,3,4] 
thiadiazol-6-yl)-chromen-2-ones and its derivatives. 
 
Results and Discussions 
The compounds (3) were synthesized by the 
reaction of various 3-(2-bromacetyl)-chromen-2-ones 
(1) with 2-amino-5-thiomethyl/benzyl [1,3,4] 
thiadiazole (2) in anhydrous ethanol, (Scheme I). The 
experimental procedure is very simple and products 
obtained were in good yields (80-90%). 
Structures of all the newly synthesized compounds 
are well supported by spectral data such as IR, NMR, 
Mass and elemental analysis. The proton NMR 
spectrum of 3a showed characteristic peaks at  2.75 
(s, 3H of SCH3), C4-H of coumarin at  8.50 (S,1H) 
and imidazo[2,1-b][1,3,4] thiadiazoles proton at  
8.62 (s,1H), the remaining aromatic protons were 
appeared at usual region. The molecular ion peak 
showed at m/z 316. 
In the first step of the reaction between 1 and 2, the 
cyclic secondary nitrogen of the thiadiazole replaces 
the bromine of the 3-(2-bromo acetyl) coumarin to 
give the intermediate (6). This on subsequent 
cyclodehydration yields the products (3 and 5, 
Scheme II). 
Attempts to isolate the intermediate were futile as 
the final product was directly obtained under different 
reaction conditions and media. The prepared final 
compounds 3 and 5 were tested chemically and 
proved to have sulphur (Lassigne’s test) but no 
halogen (Beilstein’s test and Lassaigne’s test). 
Another possible isomeric structure (7) (Figure 1) 
can be proposed for the prepared compounds. 
However this structure (7) can be readily discarded 
basing on the fact that in the thiadiazole system, the 





. Hence, the preferential attack starts 
with this center leading to structure 3 and 5 only. 
 
Experimental Section 
Melting points were determined on a Cintex 
melting  point  apparatus   and  are  uncorrected.   The  

















purity of compounds was checked by TLC plates (E. 
Merck, Mumbai, India). IR spectra (KBr) were 
recorded on a Bruker WM-400 spectrometer. 
1
H-
NMR spectra were recorded on Buckner WM-300 
spectrometer (in  ppm) using TMS as internal 
standard. Mass Spectra (EI-MS) were determined on 
Jeol-D-300 Spectrometer at 70 ev. The 3-(2-
bromoacetyl)-chromen-2-ones
17
 and [1,3,4] thiadiazoles
16
  
were prepared by reported procedures
17
. 
General procedure for the synthesis 3-(2-
substituted sulfanyl-imidazo[2,1-b][1,3,4]thiadiazol 
-6-yl)-chromen-2-one (3a-m and 5a-b). Compound 
1 (or) 4 (0.001 mole) was dissolved in anhydrous 
ethanol (10ml) then added compound 2 (0.001 mole). 
The reaction mixture was refluxed for 3-4 hours. Then 
the mixture was cooled at room temperature. The 
solid separated was filtered and washed with cold 
ethanol, water, dried and recrystallised from 




methanol. All the other compounds were synthesized 
similarly (3b-m and 5a-b). 
3-(2-Methyl sulfanyl-imidazo[2,1-b][1,3,4]thiadiazol-
5-yl) -chromen-2-one (3a): Brown Solid. Yield 90%. 
m.p. 228-230
o





H NMR (200 MHz, DMSO-d6):  
2.75 (s, 3H, -CH3), 7.35-7.96 (m, 4H, Ar-H), 8.45 (s, 
1H, C4-H of Coumarin); 8.55 (s, 1H, imidazo thiazole 
proton); MS: m/z 315 (Molecular ion). Anal. calcd. 
for C14H9N3S2O2: C, 53.32; H, 2.888; N, 13.32. 
Found: C, 53.27; H, 2.80; N, 13.24.  
3-(2-Benzyl sulfanyl-imidazo[2,1-b][1,3,4]thiadiazol-
6-yl) -chromen-2-one (3b): Brown Solid. Yield 85%. 
m.p. 223-225
o





H NMR (200 MHz, DMSO-d6):  
4.56 (s, 2H, benzyl-CH2-S), 7.35-7.78 (m, 9H, Ar-H), 
8.50 (s, 1H, C4-H of Coumarin); 8.66 (s,1H, imidazo 
thiazole proton); MS: m/z 391 (Molecular ion). Anal. 
calcd. for C20H13N3S2O2: C, 61.36; H, 3.35; N, 10.73, 
Found: C, 61.25; H, 3.26; N, 10.68. 
3-(2-Benzylsulfanyl-imidazo[2,1-
b][1,3,4]thiadiazol-6-yl) -8-methoxy-chromen-2-one 
(3c). Brown Solid. Yield 87%. m.p. 227-229
o
C. IR 





NMR (200 MHz, DMSO-d6):  4.60 (s, 3H, -OCH3), 
4.55 (s, 2H, -S-CH2-), 7.26-7.82 (m, 8H, Ar-H), 8.45 (s, 
1H, C4-H of coumarin); 8.63 (s, 1H, imidazo thiazole 
proton); MS: m/z 421 (Molecular ion). Anal. calcd. for 
C21H15N3S3O2: C, 59.84; H, 3.59; N, 9.97, Found: C, 
59.76; H, 3.47; N, 9.83. 
3-(2-Benzylsulfanyl-imidazo[2,1-b][1,3,4]thiadiazol-
6-yl) -6-chloro-chromen-2-one (3d): Brown Solid. 
Yield 83%. m.p. 161-163
o
C. IR (KBr): 1720 (lactone, 




H NMR (200 MHz, 
DMSO-d6):  4.60 (s, 2H, -S-CH2-for benzyl), 7.27-
7.50 (m, 3H, Ar-H), 7.55-7.88 (m, 5H, Ar-H); 8.40 (s, 
1H, C4-H of coumarin); 8.66 (s,1H, imidazo thiazole 
proton); MS: m/z 425 (Molecular ion). Anal. calcd. 
for C20H12ClN3O2S2: C, 56.40; H, 2.84; N, 9.87, 
Found: C, 56.33; H, 2.76; N, 9.73. 
3-(2-Benzyl sulfanyl-imidazo [2,1-b] [1,3,4] 
thiadiazol-6-yl)-6,8-dichloro-chromen-2-one (3e): 
Brown Solid. Yield 86%. m.p. 198-200
o
C. IR (KBr): 





(200MHz, DMSO-d6):  4.56 (s, 2H, -S-CH2-for 
benzyl), 7.20 (d, 1H, Ar-H, J = 3Hz), 7.47 (d, 1H, Ar-
H, J = 3Hz); 7.50-7.87 (m, 5H, Ar-H), 8.48 (s,1H, C4-
H of coumarin); 8.68 (s, 1H, imidazo thiazole proton); 
MS: m/z 460 (Molecular ion). Anal. calcd. for 
C20H11Cl2N3O2S2: C, 52.18; H, 2.41; N, 9.13, Found: 
C, 52.06; H, 2.34; N, 9.08. 
3-(2-Benzyl sulfanyl-imidazo [2,1-b] [1,3,4] 
thiadiazol-6-yl)-6-bromo-chromen-2-one (3f): 
Brown Solid. Yield 84%. m.p. 216-218
o
C. IR (KBr): 





(200 MHz, DMSO-d6):  4.56 (s, 2H, -S-CH2-for 
benzyl), 7.45 (d, 1H, J = 7Hz, C8-H of coumarin), 
7.66 (d, 1H, J = 8Hz, C7 or coumarin); 7.84 (d, 1H,  
J = 2Hz, C5 of coumarin); 7.88-8.20 (m, 5H, Ar-H); 
8.69 (s, 1H, C4 of coumarin), 8.80 (s, 1H, imidazo 
thiazole proton); MS: m/z 470 (Molecular ion). Anal. 
calcd. for C20H12BrN3O2S2: C, 51.07; H, 2.57; N, 
8.93, Found: C, 51.01; H, 2.49; N, 8.86. 
3-(2-Benzylsulfanyl-imidazo[2,1-b][1,3,4]thiadiazol- 
6-yl)-6,8-dibromo-chromen-2-one (3g): Brown 
Solid. Yield 88%. m.p. 226-228
o
C. IR (KBr): 1721 




H NMR (200 
MHz, DMSO-d6):  4.57 (s, 2H, -S-CH2-for benzyl), 
7.33 (d, 1H, C7 of coumarin, J = 8Hz), 7.46 (d, 1H, C5 
of coumarin, J = 2 Hz); 7.50-7.99 (m, 5H, Ar-H), 
8.5(s, 1H, C4 of coumarin); 8.65 (s, 1H, imidazo 
thiazole proton); MS: m/z 549 (Molecular ion). Anal. 
calcd. for C20H11Br2N3O2S2: C, 43.74; H, 2.02; N, 
7.65, Found: C, 43.66; H, 1.94; N, 7.54. 
3-[2-(4-Nitro-benzylsulfanyl-imidazo[2,1-b][1,3,4] 
thiadiazol-6-yl)- 
chromen-2-one (3h): Brown Solid. Yield 78%. 
m.p. 206-208
o





H NMR (200 MHz, DMSO-d6):  
4.56 (s, 2H, -S-CH2-for benzyl), 7.33-7.64 (m, 4H, 
Ar-H), 7.88-7.90 (d, d, 2H, Ar-H); 7.98-8.00  
(d, d, 2H, Ar-H), 8.51 (s, 1H, C4 of coumarin); 8.60 
(s, 1H, imidazo thiazole proton); MS: m/z 436 
(Molecular ion). Anal. calcd. for C20H12N4O4S2: C, 




Brown Solid. Yield 76%. m.p. 210-212
o
C. IR (KBr): 





(200 MHz, DMSO-d6):  4.6 (s, 3H, -OCH3), 4.50  
(s, 2H, -S-CH2- for benzyl), 7.33-7.60 (m, 3H, Ar-H); 
7.71-7.78 (d, d, 2H, Ar-H), 7.80-7.88 (d, d, 2H, Ar-
H); 8.55 (s, 1H, Ar-H); 8.60 (s, 1H, imidazo thiazole 
proton); MS: m/z 466 (Molecular ion). Anal. calcd. 
for C21H14N4O5S2: C, 54.07; H, 3.03; N, 12.01, Found: 
C, 53.96; H, 2.95; N, 11.94. 
3-[2-(4-Nitro-benzylsulfanyl-imidazo[2,1-b][1,3,4] 
thiadiazol-6-yl)-6-chloro-chromen-2-one (3j). 




Brown Solid. Yield 76%. m.p. 204-208
o
C. IR (KBr): 





(200 MHz, DMSO-d6):  4.54 (s, 2H, -S-CH2-for 
benzyl), 7.30-7.60 (m, 3H, Ar-H), 7.70-7.76 (d, d, 2H, 
Ar-H); 7.80-7.98 (d, d, 2H, Ar-H), 8.55 (s, 1H, C4 
coumarin); 8.65 (s, 1H, imidazo thiazole proton); MS: 
m/z 470 (Molecular ion). Anal. calcd. for 
C20H11ClN4O4S2: C, 51.01; H, 2.35; N, 11.90, Found: 
C, 49.96; H, 2.27; N, 11.87. 
3-[2-(4-Nitro-benzylsulfanyl-imidazo [2,1-b] [1,3,4] 
thiadiazol-6-yl)-6,8-dichloro-chromen-2-one (3k): 
Brown Solid. Yield 78%. m.p. 242-246
o
C. IR (KBr): 





(200 MHz, DMSO-d6):  4.56 (s, 2H, -S-CH2 for 
benzyl), 7.35 (d, 1H, C7 of coumarin, J = 3Hz), 7.55 
(d, 1H, C5 of coumarin); 7.60-7.75 (d, d, 2H, Ar-H), 
7.80-7.92 (d, d, 2H, Ar-H); 8.54 (s, 1H, C4 of 
coumarin); 8.66 (s, 1H, imidazo thiazole proton); ); 
MS: m/z 505 (Molecular ion). Anal. calcd. for 
C20H10Cl2N4O4S2: C, 47.53; H, 47.53; N, 11.09, 
Found: C, 47.47; H, 1.85; N, 11.02. 
3-[2-(4-Nitro-benzylsulfanyl-imidazo[2,1-b][1,3,4] 
thiadiazol-6-yl)-6-bromo-chromen-2-one (3l): 
Brown Solid. Yield 76%. m.p. 250-252
o
C. IR (KBr): 





(200 MHz, DMSO-d6):  4.53 (s, 2H, -S-CH2 for 
benzyl), 7.50-7.67 (m, 3H, Ar-H), 7.71-7.83 (d, d, 2H, 
Ar-H); 7.85-7.88 (d, d, 2H, Ar-H), 8.51 (s, 1H, C4 of 
coumarin); 8.66 (s, 1H, imidazo thiazole proton); MS: 
m/z 515 (Molecular ion). Anal. calcd. for 
C20H11BrN4O4S2: C, 46.61; H, 2.15; N, 10.87, Found: 
C, 46.54; H, 2.09; N, 10.81. 
3-[2-(4-Nitro-benzylsulfanyl-imidazo[2,1-b][1,3,4] 
thiadiazol-6-yl)-6,8-dibromo-chromen-2-one (3m): 
Brown Solid. Yield 78%. m.p. 264-268
o
C. IR (KBr): 





(200 MHz, DMSO-d6):  4.56 (s, 2H, -S-CH2 for 
benzyl), 7.45 (d, 1H, C7 of coumarin, J = 8 Hz), 
7.69(d, 1H, C5 of coumarin, J = 2Hz); 7.75-7.78 (d, d, 
2H, Ar-H), 7.81-7.96 (d, d, 2H, Ar-H), 8.54 (s, 1H, C4 
of coumarin); 8.67 (s, 1H, imidazo thiazole proton); 
MS: m/z 594 (Molecular ion). Anal. calcd. for 
C20H10Br2N4O4S2: C, 40.42; H, 1.70; N, 9.43, Found: 
C, 40.38; H, 1.66; N, 9.37. 
3-(2-Benzylsulfanyl-imidazo[2,1-b][1,3,4]thiadiazol -
6-yl)-benzo[b]-chromen-2-one (5a). Brown Solid. 
Yield 80%. m.p. 177-179
o
C. IR (KBr): 1726 (lactone, 




H NMR (200 MHz, 
DMSO-d6):  4.67 (s, 2H, -S-CH2-for benzyl), 7.30-
7.76 (m, 6H, Ar-H), 7.80-8.00 (m, 5H, Ar-H); 8.45  
(s, 1H, C4 of coumarin), 8.87 (s, 1H, imidazo thiazole 
proton); MS: m/z 441 (Molecular ion). Anal. calcd. 
for C24H15N3O2S2: C, 65.29; H, 3.42; N, 9.52, Found: 
C, 65.21; H, 3.36; N, 9.45. 
 
Conclusion 
In conclusion, we have described a series of 
sulfanyl-imidazo [2,1-b] [1,3,4]-thiadiazole and their 
derivatives have been synthesized from easily 
available starting materials. The title compounds were 
obtained by the single step, with a simple and 
convenient method (conventional) in good yields, 
without any side products.  
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